MediBeacon
MediBeacon specializes in the advancement of fluorescent tracer agents and transdermal detection focused on providing actionable organ function assessment.
The MediBeacon® Transdermal GFR System (TGFR) is a first-in-kind device for point of care kidney function assessment in adult patients with normal or impaired renal function. Transdermal GFR methodology is designed to be effective without age, weight, sex, gender, race, or ethnicity inputs and has approval in select countries.
Potential applications in gastroenterology, ophthalmology, and surgery are in various stages of clinical development.
